1. Home
  2. GPAT vs SEPN Comparison

GPAT vs SEPN Comparison

Compare GPAT & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPAT
  • SEPN
  • Stock Information
  • Founded
  • GPAT 2020
  • SEPN 2022
  • Country
  • GPAT United States
  • SEPN United States
  • Employees
  • GPAT N/A
  • SEPN N/A
  • Industry
  • GPAT
  • SEPN
  • Sector
  • GPAT
  • SEPN
  • Exchange
  • GPAT NYSE
  • SEPN NYSE
  • Market Cap
  • GPAT N/A
  • SEPN 899.5M
  • IPO Year
  • GPAT 2024
  • SEPN 2024
  • Fundamental
  • Price
  • GPAT $10.07
  • SEPN $25.91
  • Analyst Decision
  • GPAT
  • SEPN
  • Analyst Count
  • GPAT 0
  • SEPN 0
  • Target Price
  • GPAT N/A
  • SEPN N/A
  • AVG Volume (30 Days)
  • GPAT 39.6K
  • SEPN 519.2K
  • Earning Date
  • GPAT 01-01-0001
  • SEPN 11-19-2024
  • Dividend Yield
  • GPAT N/A
  • SEPN N/A
  • EPS Growth
  • GPAT N/A
  • SEPN N/A
  • EPS
  • GPAT 0.17
  • SEPN N/A
  • Revenue
  • GPAT N/A
  • SEPN $838,000.00
  • Revenue This Year
  • GPAT N/A
  • SEPN N/A
  • Revenue Next Year
  • GPAT N/A
  • SEPN N/A
  • P/E Ratio
  • GPAT $60.40
  • SEPN N/A
  • Revenue Growth
  • GPAT N/A
  • SEPN N/A
  • 52 Week Low
  • GPAT $9.98
  • SEPN $18.62
  • 52 Week High
  • GPAT $10.10
  • SEPN $26.34
  • Technical
  • Relative Strength Index (RSI)
  • GPAT N/A
  • SEPN N/A
  • Support Level
  • GPAT N/A
  • SEPN N/A
  • Resistance Level
  • GPAT N/A
  • SEPN N/A
  • Average True Range (ATR)
  • GPAT 0.00
  • SEPN 0.00
  • MACD
  • GPAT 0.00
  • SEPN 0.00
  • Stochastic Oscillator
  • GPAT 0.00
  • SEPN 0.00

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

Share on Social Networks: